Literature DB >> 27732034

A randomized controlled trial of cognitive remediation and work therapy in the early phase of substance use disorder recovery for older veterans: Neurocognitive and substance use outcomes.

Morris D Bell1, Holly B Laws1, Ismene B Petrakis1.   

Abstract

OBJECTIVE: Cognitive remediation therapy (CRT) is reported to improve neurocognitive and substance use disorder (SUD) outcomes in residential treatments. This National Institute of Drug Abuse funded pilot study reports on CRT as an augmentation to outpatient treatment for SUD.
METHOD: Recovering outpatient veterans were randomized into CRT + Work Therapy (n = 24) or work therapy (n = 24) with treatment-as-usual. Blind assessments of neurocognition and substance use were performed at baseline, 3 months (end of treatment), and 6-month follow-up.
RESULTS: Baseline assessments revealed high rates of cognitive impairment with 87.5% showing significant decline from premorbid IQ on at least 1 measure (median = 3/14 measures). Adherence to treatment was excellent. Follow-up rates were 95.7% at 3 months and 87.5% at 6 months. Mixed effects models of cognitive change over time revealed significant differences favoring CRT + Work Therapy on working memory (WM) and executive function indices. Global index of cognition showed a nonsignificant trend (effect size [ES] = .37) favoring CRT + Work Therapy. SUD outcomes were excellent for both conditions. CRT + Work Therapy had a mean of 97% days of abstinence at 3 months, 94% in the 30 days prior to 6-month follow-up, and 24/26 weeks of total abstinence; differences between conditions were not significant. CONCLUSIONS AND IMPLICATIONS FOR PRACTICE: CRT was well accepted by outpatient veterans with SUDs and led to significant improvements in WM and executive functions beyond that of normal cognitive recovery. No difference between conditions was found for SUD outcomes, perhaps because work therapy obscured the benefits of CRT. (PsycINFO Database Record (c) 2017 APA, all rights reserved).

Entities:  

Mesh:

Year:  2016        PMID: 27732034      PMCID: PMC5378626          DOI: 10.1037/prj0000211

Source DB:  PubMed          Journal:  Psychiatr Rehabil J        ISSN: 1095-158X


  29 in total

1.  Neurocognitive enhancement therapy with work therapy in schizophrenia: 6-month follow-up of neuropsychological performance.

Authors:  Morris Bell; Joanna Fiszdon; Tamasine Greig; Bruce Wexler; Gary Bryson
Journal:  J Rehabil Res Dev       Date:  2007

Review 2.  The role of executive cognitive functions in changing substance use: what we know and what we need to know.

Authors:  Arthur W Blume; G Alan Marlatt
Journal:  Ann Behav Med       Date:  2009-03-28

Review 3.  Neurotoxicity and neurocognitive impairments with alcohol and drug-use disorders: potential roles in addiction and recovery.

Authors:  S C Bowden; F T Crews; M E Bates; W Fals-Stewart; M L Ambrose
Journal:  Alcohol Clin Exp Res       Date:  2001-02       Impact factor: 3.455

4.  The Continuous Performance Test, identical pairs version (CPT-IP): I. New findings about sustained attention in normal families.

Authors:  B A Cornblatt; N J Risch; G Faris; D Friedman; L Erlenmeyer-Kimling
Journal:  Psychiatry Res       Date:  1988-11       Impact factor: 3.222

5.  Effects of neurocognitive enhancement therapy in schizophrenia: normalisation of memory performance.

Authors:  Morris D Bell; Joanna Fiszdon; Gary Bryson; Bruce E Wexler
Journal:  Cogn Neuropsychiatry       Date:  2004-08       Impact factor: 1.871

6.  Computer-assisted cognitive rehabilitation for the treatment of patients with substance use disorders: a randomized clinical trial.

Authors:  William Fals-Stewart; Wendy K K Lam
Journal:  Exp Clin Psychopharmacol       Date:  2010-02       Impact factor: 3.157

7.  Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

Authors:  Raymond F Anton; Stephanie S O'Malley; Domenic A Ciraulo; Ron A Cisler; David Couper; Dennis M Donovan; David R Gastfriend; James D Hosking; Bankole A Johnson; Joseph S LoCastro; Richard Longabaugh; Barbara J Mason; Margaret E Mattson; William R Miller; Helen M Pettinati; Carrie L Randall; Robert Swift; Roger D Weiss; Lauren D Williams; Allen Zweben
Journal:  JAMA       Date:  2006-05-03       Impact factor: 56.272

8.  Substance abuse treatment outcomes for cognitively impaired and intact outpatients.

Authors:  Gordon Teichner; Michael D Horner; John C Roitzsch; Janice Herron; Angelica Thevos
Journal:  Addict Behav       Date:  2002 Sep-Oct       Impact factor: 3.913

9.  Relation between cognitive testing performance and pattern of substance use in males at treatment entry.

Authors:  Gregory W Schrimsher; Jefferson D Parker; Randy S Burke
Journal:  Clin Neuropsychol       Date:  2007-05       Impact factor: 3.535

10.  Cognitive Training and Work Therapy for the Treatment of Verbal Learning and Memory Deficits in Veterans With Alcohol Use Disorders.

Authors:  Morris D Bell; Nicholas A Vissicchio; Andrea J Weinstein
Journal:  J Dual Diagn       Date:  2016
View more
  7 in total

Review 1.  The role of attention control in complex real-world tasks.

Authors:  Christopher Draheim; Richard Pak; Amanda A Draheim; Randall W Engle
Journal:  Psychon Bull Rev       Date:  2022-02-15

2.  Randomized clinical trial of Cognitive Remediation Therapy with Work Therapy in the early phase of substance use disorder recovery for older Veterans: 12-Month follow-up.

Authors:  Morris D Bell; Bharath Muppala; Andrea J Weinstein; David Ciosek; Brian Pittman; Ismene Petrakis; Joanna M Fiszdon
Journal:  J Subst Abuse Treat       Date:  2020-02-01

Review 3.  Cognitive Remediation as an Adjunct Treatment for Substance Use Disorders: A Systematic Review.

Authors:  Talia Nardo; Jennifer Batchelor; Jamie Berry; Heather Francis; Deyyan Jafar; Thomas Borchard
Journal:  Neuropsychol Rev       Date:  2021-04-19       Impact factor: 7.444

4.  Neurocognitive Empowerment for Addiction Treatment (NEAT): study protocol for a randomized controlled trial.

Authors:  Hamed Ekhtiari; Tara Rezapour; Brionne Sawyer; Hung-Wen Yeh; Rayus Kuplicki; Mimi Tarrasch; Martin P Paulus; Robin Aupperle
Journal:  Trials       Date:  2021-05-07       Impact factor: 2.279

Review 5.  Current Status of Cognitive Remediation for Psychiatric Disorders: A Review.

Authors:  Eun Jin Kim; Yong-Chun Bahk; Hyeonju Oh; Won-Hye Lee; Jong-Sun Lee; Kee-Hong Choi
Journal:  Front Psychiatry       Date:  2018-10-01       Impact factor: 4.157

Review 6.  A Roadmap for Integrating Neuroscience Into Addiction Treatment: A Consensus of the Neuroscience Interest Group of the International Society of Addiction Medicine.

Authors:  Antonio Verdejo-Garcia; Valentina Lorenzetti; Victoria Manning; Hugh Piercy; Raimondo Bruno; Rob Hester; David Pennington; Serenella Tolomeo; Shalini Arunogiri; Marsha E Bates; Henrietta Bowden-Jones; Salvatore Campanella; Stacey B Daughters; Christos Kouimtsidis; Dan I Lubman; Dieter J Meyerhoff; Annaketurah Ralph; Tara Rezapour; Hosna Tavakoli; Mehran Zare-Bidoky; Anna Zilverstand; Douglas Steele; Scott J Moeller; Martin Paulus; Alex Baldacchino; Hamed Ekhtiari
Journal:  Front Psychiatry       Date:  2019-12-23       Impact factor: 4.157

Review 7.  The Role of Working Memory for Cognitive Control in Anorexia Nervosa versus Substance Use Disorder.

Authors:  Samantha J Brooks; Sabina G Funk; Susanne Y Young; Helgi B Schiöth
Journal:  Front Psychol       Date:  2017-09-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.